Amylyx Pharmaceuticals Inc (AMLX) extends its cash runway into 2028 while navigating clinical trial complexities and market opportunities.
Grounded in unified data, new offering turns AI ambition into high-impact adoption through human-led expertise NEW ...
FICO, a leader in global analytics software, is returning to Richard Childress Racing (RCR) in 2026, serving as a multi-race primary sponsor for NASCAR Cup Seri ...
Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results